South Korea Hormonal Contraceptive Market Size & Outlook

The hormonal contraceptive market in South Korea is expected to reach a projected revenue of US$ 134.0 million by 2030. A compound annual growth rate of 4.4% is expected of South Korea hormonal contraceptive market from 2025 to 2030.
Revenue, 2024 (US$M)
$103.7
Forecast, 2030 (US$M)
$134.0
CAGR, 2025 - 2030
4.4%
Report Coverage
South Korea

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

South Korea hormonal contraceptive market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

South Korea hormonal contraceptive market highlights

  • The South Korea hormonal contraceptive market generated a revenue of USD 103.7 million in 2024 and is expected to reach USD 134.0 million by 2030.
  • The South Korea market is expected to grow at a CAGR of 4.4% from 2025 to 2030.
  • In terms of segment, iud was the largest revenue generating method in 2024.
  • Implant is the most lucrative method segment registering the fastest growth during the forecast period.


Hormonal contraceptive market data book summary

Market revenue in 2024USD 103.7 million
Market revenue in 2030USD 134.0 million
Growth rate4.4% (CAGR from 2025 to 2030)
Largest segmentIud
Fastest growing segmentImplant
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPill, IUD, Injectable, Vaginal Ring, Implant, Patch
Key market players worldwideAbbVie Inc, Afaxys, Teva Pharmaceutical Industries Ltd, Bayer AG, Organon Group of Companies, Pfizer Inc, Agile Therapeutics Inc, Janssen Pharmaceuticals NV, Lupin, Pregna International


Other key industry trends

  • In terms of revenue, South Korea accounted for 0.6% of the global hormonal contraceptive market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, India hormonal contraceptive market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,524.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Hormonal Contraceptive Market Companies

Name Profile # Employees HQ Website
Organon Group of Companies View profile - - -
Janssen Pharmaceuticals NV View profile - - -
Pregna International View profile 51-100 Mumbai, Maharashtra, India, Asia https://www.pregna.com/
Afaxys View profile 1-10 Charleston, South Carolina, United States, North America https://www.afaxys.com/
Agile Therapeutics Inc View profile 19 500 College Road East, Suite 310, Princeton, NJ, United States, 08540 https://www.agiletherapeutics.com
Bayer AG View profile 99723 Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 https://www.bayer.com
Lupin View profile 10001+ Mumbai, Maharashtra, India, Asia https://www.lupin.com
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com
AbbVie Inc View profile 50000 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 http://www.abbvieinvestor.com
Teva Pharmaceutical Industries Ltd View profile 37851 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 https://www.tevapharm.com

South Korea hormonal contraceptive market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hormonal contraceptive market will help companies and investors design strategic landscapes.


Iud was the largest segment with a revenue share of 52.27% in 2024. Horizon Databook has segmented the South Korea hormonal contraceptive market based on pill, iud, injectable, vaginal ring, implant, patch covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to South Korea hormonal contraceptive market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of South Korea hormonal contraceptive market databook

  • Our clientele includes a mix of hormonal contraceptive market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the South Korea hormonal contraceptive market , including forecasts for subscribers. This country databook contains high-level insights into South Korea hormonal contraceptive market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

South Korea Method - Hormonal Contraceptive Market size, 2024 - 2030 (US$M)

South Korea Hormonal Contraceptive Market Outlook Share, 2024 & 2030 (US$M)

South Korea Method - Hormonal Contraceptive Market size, 2024 - 2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online